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Available online 9 February 2011Secondary aortoenteric fistula (AEF) complicate 0.3e2.5%
of all open aortic surgical procedures, with the incidence
being lower following endovascular aortic aneurysm
repair.1,2 It is, however, one of the most dangerous
complications for a patient to encounter, with the highest
mortality rates being observed in patients presenting with
massive haemorrhage.
In the past, patients with secondary AEF have usually
been treated with total graft excision and either over-
sewing of the aortic stump and extra anatomic revascu-
larisation or in-situ replacement with a rifampicin bonded
prosthesis or (less commonly) deep venous conduits.
Because of the considerable morbidity and mortality asso-
ciated with these difficult and prolonged redo open
procedures; the emergence of an endovascular solution has
been actively welcomed.
There are considerable theoretical attractions associ-
ated with the endovascular treatment of secondary AEF,
most notably; reduced physiological stresses to the patient,
shorter operating times, less trauma and reduced trans-
fusion requirements, all of which translate into lower
mortality and morbidity.3 However, following the publica-
tion of several small case series from around the world,
there are now concerns that while the endovascular
treatment of AEF may confer better short term outcomes,
this may come with a heavy price in the long term. In
effect; the endovascular treatment of secondary AEF mayDOI of original article: 10.1016/j.ejvs.2010.12.026.
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This seems to be the conclusion of the paper by Kakkos
et al, who report early and long term outcomes following
either open or endovascular repair of secondary AEF from
six vascular institutions in Greece over a twelve year
period.5
Theirs is now the largest study published to date and
provides further insight into the best way to manage these
difficult patients. Out of the 25 patients, eight were
treated via an endovascular approach, while 17 underwent
open repair. Whilst the authors claim that these groups
were comparable, the treatments they underwent were not
standardised. In the endovascular group, treatments
ranged from the insertion of extension cuffs to cover the
defect, relining the entire graft or aorto-uniliac stent graft
deployment plus femoroefemoral cross over. Unfortu-
nately, there is no mention of the devices used in the Greek
series, nor whether suprarenal fixation was utilised. The
issue of suprarenal fixation is important as it will make any
subsequent open operation even more difficult to complete
safely. In the open group, treatment varied from simple
suture of the anastomotic defect, to complete removal of
the graft and there were varying strategies for dealing with
the bowel defect (primary closure, resection etc).
So does the Greek series provide the reader with better
insight as to how secondary AEF should be treated? From this
study, and those others published within the last two years,
there is no doubt that patients treated via the endovascular
approach have much better outcomes in the short term
(lower mortality and morbidity) as compared to open
repair.4,6 However, the Achilles’ heel remains secondaryd by Elsevier Ltd. All rights reserved.
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naı¨ve to have expected otherwise, as the endovascular
stent/cuff now lies in close proximity to the bowel defect
rather than the original aortic anastomosis and is highly likely
to become infected despite antibiotic therapy.
As a consequence, the concept of endovascular repair
becoming a ‘bridging’ procedure has made it the first
choice therapy for many.6 If nothing else, it does allow
a critically ill patient (who would otherwise likely have
died) to enjoy an extension to life, albeit sometimes a short
one. But when does the endovascular approach become
a ‘bridge to nowhere’, rather than a precursor to a defini-
tive elective intervention designed to prolong life with the
minimum risk of reinfection?
The authors of the Greek series have concluded that
further trials are required to look at the precise role of
endovascular repair as a ‘bridging treatment’. The unfor-
tunate reality, however, is that thoughts about these trials
are simply utopian and idealistic, as they are never likely to
take place. Because of the declining number of patients
undergoing open aneurysm repair, vascular units will
encounter fewer and fewer patients with secondary AEF. As
a consequence, even if a large number of vascular institu-
tions were to collaborate in a prospective audit, it is
extremely unlikely that sufficient patient numbers would
accrue to determine optimal practice.
So what new information or guidance have I obtained
from this paper. Firstly; the Greek series has corroborated
our own anecdotal series here in Leicester. Patients with
secondary AEF do much better with endovascular treat-
ment, but all eventually succumb to recurrent infection
and/or rebleeding. Like our Greek colleagues, we have
never been able to define when we should take the
‘bridging’ concept to its natural conclusion. In reality, it is
very difficult to recommend to a now fit and healthy patient
that he/she should undergo a complex and ultimately
dangerous reintervention when he/she feels back to
normal. Sadly, it then usually becomes too late to safely
remove an endovascular device and the original aortic graft
when reinfection and bleeding strikes again and the patient
is at his/her physiological weakest. The latter treatmentstrategy was suggested by the Greek surgeons in their paper
as one solution to the ‘bridging’ dilemma, but it is salutary
to observe that every patient treated in this way died.
Accordingly, it seems likely that endovascular repair will
become the first line treatment in most patients with
secondary AEF. However, it is incumbent on surgeons and
interventionists to formally discuss with their patients
(after they have made a full recovery) as to whether they
wish to accept the almost inevitable consequences of late
reinfection (should no further intervention be undertaken
electively) or whether they wish to be considered for
a definitive secondary open surgical intervention when they
are at their physiological fittest. Unless new evidence
emerges to the contrary, avoiding such a discussion and
simply deferring redo open surgery until the patient pres-
ents with another massive haemorrhage is almost certainly
going to end in the patient’s death.References
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